Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1996
12/19/1996WO1996040270A1 In vitro packaging of adeno-associated virus dna
12/19/1996WO1996040269A1 INCREASING rAAV TITER
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040266A1 Method of treatment for asthma
12/19/1996WO1996040265A1 Stabilization of polynucleotide complexes
12/19/1996WO1996040264A1 Separation of active complexes
12/19/1996WO1996040240A1 Helper virus-free aav production
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040212A1 Retrovirus vectors for expression of cii-ta and activation of hla class ii gene expression and uses thereof
12/19/1996WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040195A1 Gene therapy for myocardial ischemia
12/19/1996WO1996040178A1 Use of co-localized islets and sertoli cells in xenograft cellular transplants
12/19/1996WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040081A2 Oral delivery of gene constructs
12/19/1996WO1996040068A1 Methods and system for processing dispersible fine powders
12/19/1996WO1996040067A1 Cationic lipid acid salt of 3 beta [n-(n',n'-dimethylaminoethane)-carbamoyl] cholesterol
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039830A1 Pericardial therapeutic and diagnostic agent delivery
12/19/1996DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996CA2226463A1 Recombinational cloning using engineered recombination sites
12/19/1996CA2224226A1 Immunoprotective barrier for transplantation of cells
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224114A1 Synthetic mammalian chromosome and methods for construction
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2224064A1 Methods and system for processing dispersible fine powders
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223934A1 Separation of active complexes
12/19/1996CA2223928A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223923A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223921A1 Stabilization of polynucleotide complexes
12/19/1996CA2223891A1 Treatment of insulin resistance
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996CA2223246A1 Cell line producing analgesic compounds for treating pain
12/19/1996CA2223179A1 Phosphonic acid-based cationic lipids
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2222793A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996CA2222574A1 Oral delivery of adeno-associated viral vectors
12/19/1996CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell
12/19/1996CA2222534A1 In vitro packaging of adeno-associated virus dna
12/19/1996CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna
12/19/1996CA2222162A1 Pericardial therapeutic and diagnostic agent delivery
12/19/1996CA2221821A1 Endothelial-monocyte activating polypeptide iii
12/19/1996CA2221710A1 Gene therapy for myocardial ischemia
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221602A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996CA2221323A1 Oral delivery of gene constructs
12/18/1996EP0748870A2 Oncostatin M induced hematopoiesis
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996CN1138295A A novel tumor suppressor gene
12/17/1996US5585362 Adenovirus vectors for gene therapy
12/17/1996US5585263 Nucleotide sequence effecting the rev-dependent expression of structural proteins, gag, pol and env, in the absence of rev expression; hiv vaccine;
12/17/1996US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
12/17/1996US5584807 Gas driven gene delivery instrument
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/16/1996CA2220988A1 Fibroblast growth factor 13
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039540A1 Novel gene-up regulated in regenerating liver
12/12/1996WO1996039531A1 Delivery of nucleotides into organisms by electroporation
12/12/1996WO1996039530A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
12/12/1996WO1996039524A1 Methods for enhancement of protective immune responses
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039521A1 Human chemokine beta-13
12/12/1996WO1996039517A1 The erf genetic locus and its products
12/12/1996WO1996039516A2 Targets for breast cancer diagnosis and treatment
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039506A1 Fibroblast growth factor-14
12/12/1996WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039496A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996WO1996039495A1 Aav directed targeted integration
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039490A1 Organ function replacement compositions and methods of making and using the same
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039438A1 G-protein receptor hibeb69
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039435A1 Human g-protein receptor hpraj70
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039431A1 Bone morphogenic protein-10
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use